Keyword: Pharmacyclics

News

AstraZeneca Confirms Talks with Acerta

15.12.2015 - AstraZeneca has confirmed speculation that it is “exploring potential strategic options” with Acerta Pharma, a privately owned biotech firm with operations in the Netherlands and...

News

AbbVie Completes Pharmacyclics Acquisition

28.05.2015 - AbbVie has completed the acquisition of Pharmacyclics, a deal the Chicago-based US drugmaker says enhances its scientific and commercial presence in oncology. As a wholly owned...

News

PwC Sees Pharmaceuticals, Life Sciences in M&A Surge

18.05.2015 - The pharmaceuticals and life sciences sectors saw 35 mergers and acquisitions worth $166.3 billion in the first three months of 2015, a value that eclipsed transactions from all of...

News

Mylan Makes $29 Billion Bid for Perrigo

12.04.2015 - Generic drugmaker Mylan has made an offer of $ $28.86 billion in stock and cash to acquire rival Perrigo. A merger of the two major players would create a leader in specialty drugs...

News

AbbVie to Acquire Pharmacyclics for $21 Billion

05.03.2015 - US drugmaker AbbVie has reached final agreement to acquire compatriot Pharmacyclics and the company's flagship asset Imbruvica (ibrutinib), which it describes as "a highly...